ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards
In Brief: Fidler Wins BMS Cancer Research Award; Thomas Cech To Head Howard Hughs Inst.
Capitol Hill: Bills Seeks Coverage for Treatment Of cancers Found in CDC Screening
Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says
Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants
In Brief: Ahoy! It’s “Admiral Rick”
Professional Societies: AACR Awards Honor 8 Scientists, Clinicians
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final
